USD566549S1 - Cap - Google Patents

Cap Download PDF

Info

Publication number
USD566549S1
USD566549S1 US29/258,722 US25872206F USD566549S US D566549 S1 USD566549 S1 US D566549S1 US 25872206 F US25872206 F US 25872206F US D566549 S USD566549 S US D566549S
Authority
US
United States
Prior art keywords
cap
present invention
cap according
view
shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/258,722
Inventor
Rachel Russell
Odile Beranger
Aurèle Hurtis
Francis Lovell
Sandra Michaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser UK Ltd
Original Assignee
Reckitt Benckiser UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EM42111005 priority Critical
Application filed by Reckitt Benckiser UK Ltd filed Critical Reckitt Benckiser UK Ltd
Assigned to RECKITT BENCKISER (UK) LIMITED reassignment RECKITT BENCKISER (UK) LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BERANGER, ODILE, HURTIS, AURELE, LOVELL, FRANCIS, MICHAUD, SANDRA, RUSSELL, RACHEL
Application granted granted Critical
Publication of USD566549S1 publication Critical patent/USD566549S1/en
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links

Images

Description

FIG. 1 is front and left perspective view of the cap according to the present invention;

FIG. 2 is the front view of the cap according to the present invention;

FIG. 3 is the back view of the cap according to the present invention;

FIG. 4 is the top view of the cap according to the present invention;

FIG. 5 is the bottom view of the cap according to the present invention;

FIG. 6 is the left side view of the cap according to the present invention; and,

FIG. 7 is the right side view of the cap according to the present invention.

Claims (1)

  1. The ornamental design for a cap, as shown and described.
US29/258,722 2005-10-26 2006-04-25 Cap Active USD566549S1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EM42111005 2005-10-26

Publications (1)

Publication Number Publication Date
USD566549S1 true USD566549S1 (en) 2008-04-15

Family

ID=39281969

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/258,722 Active USD566549S1 (en) 2005-10-26 2006-04-25 Cap

Country Status (1)

Country Link
US (1) USD566549S1 (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD771237S1 (en) * 2014-10-02 2016-11-08 Mannkind Corporation Mouthpiece cover
USD774834S1 (en) * 2015-04-30 2016-12-27 O2Cool, Llc Bowl
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9717689B2 (en) 2005-09-14 2017-08-01 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
USD793860S1 (en) * 2016-02-01 2017-08-08 Pfizer Inc. Container
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US10130581B2 (en) 2006-02-22 2018-11-20 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US10130709B2 (en) 2011-06-17 2018-11-20 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US10201672B2 (en) 2008-06-13 2019-02-12 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10258664B2 (en) 2011-10-24 2019-04-16 Mannkind Corporation Methods and compositions for treating pain
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10342938B2 (en) 2008-06-13 2019-07-09 Mannkind Corporation Dry powder drug delivery system

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US10130685B2 (en) 2004-08-23 2018-11-20 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9717689B2 (en) 2005-09-14 2017-08-01 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US10143655B2 (en) 2005-09-14 2018-12-04 Mannkind Corporation Method of drug formulation
US10130581B2 (en) 2006-02-22 2018-11-20 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US10342938B2 (en) 2008-06-13 2019-07-09 Mannkind Corporation Dry powder drug delivery system
US10201672B2 (en) 2008-06-13 2019-02-12 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10172850B2 (en) 2008-12-29 2019-01-08 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US10130709B2 (en) 2011-06-17 2018-11-20 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US10258664B2 (en) 2011-10-24 2019-04-16 Mannkind Corporation Methods and compositions for treating pain
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
USD802116S1 (en) * 2014-10-02 2017-11-07 Mannkind Corporation Mouthpiece cover
USD771237S1 (en) * 2014-10-02 2016-11-08 Mannkind Corporation Mouthpiece cover
USD774834S1 (en) * 2015-04-30 2016-12-27 O2Cool, Llc Bowl
USD793860S1 (en) * 2016-02-01 2017-08-08 Pfizer Inc. Container

Similar Documents

Publication Publication Date Title
USD575247S1 (en) Television
USD568919S1 (en) Spectacles
USD650001S1 (en) Spectacles
USD553413S1 (en) Cushion
USD553970S1 (en) Clip
USD553983S1 (en) Cap
USD534573S1 (en) Sunglass
USD549268S1 (en) Eyewear
USD549763S1 (en) Eyewear
USD549270S1 (en) Eyewear
USD535524S1 (en) Mug
USD568921S1 (en) Spectacles
USD555486S1 (en) Bottle
USD546696S1 (en) Container
USD552077S1 (en) Headphone
USD528440S1 (en) Watch case
USD535682S1 (en) Eyeglasses
USD536028S1 (en) Eyeglasses
USD527286S1 (en) Watch
USD533802S1 (en) Ring
USD532460S1 (en) Motorbike
USD568368S1 (en) Spectacles
USD538271S1 (en) Headset
USD545759S1 (en) Battery
USD561497S1 (en) Table